381 related articles for article (PubMed ID: 35596788)
21. Concepts of multi-level dynamical modelling: understanding mechanisms of squamous cell carcinoma development in Fanconi anemia.
Velleuer E; Domínguez-Hüttinger E; Rodríguez A; Harris LA; Carlberg C
Front Genet; 2023; 14():1254966. PubMed ID: 38028610
[TBL] [Abstract][Full Text] [Related]
22. Fanconi anemia and the cell cycle: new perspectives on aneuploidy.
Nalepa G; Clapp DW
F1000Prime Rep; 2014; 6():23. PubMed ID: 24765528
[TBL] [Abstract][Full Text] [Related]
23. Genotoxic aldehydes in the hematopoietic system.
Wang M; Dingler FA; Patel KJ
Blood; 2022 Apr; 139(14):2119-2129. PubMed ID: 35148375
[TBL] [Abstract][Full Text] [Related]
24. What are the DNA lesions underlying formaldehyde toxicity?
Benedict B; Kristensen SM; Duxin JP
DNA Repair (Amst); 2024 Jun; 138():103667. PubMed ID: 38554505
[TBL] [Abstract][Full Text] [Related]
25. Evolution, structure and emerging roles of C1ORF112 in DNA replication, DNA damage responses, and cancer.
Edogbanya J; Tejada-Martinez D; Jones NJ; Jaiswal A; Bell S; Cordeiro R; van Dam S; Rigden DJ; de Magalhães JP
Cell Mol Life Sci; 2021 May; 78(9):4365-4376. PubMed ID: 33625522
[TBL] [Abstract][Full Text] [Related]
26. Successful radiotherapy of de novo hypopharyngeal cancer in a Fanconi anemia patient with previous esophageal cancer.
Babaei M; Roudini K; Shirkhoda M; Ganjalikhani M; Kolahdouzan K
Clin Case Rep; 2021 Jun; 9(6):e04159. PubMed ID: 34194758
[TBL] [Abstract][Full Text] [Related]
27. Fanconi Anemia: A Syndrome of Anemia and Skeletal Malformations Progressing to a Gene Network Involved in Genomic Stability and Malignant Disease.
Poot M
Mol Syndromol; 2020 Nov; 11(4):178-182. PubMed ID: 33224011
[No Abstract] [Full Text] [Related]
28. Transformation of an abnormal karyotype to acute erythroid leukemia in a pediatric patient with Fanconi anemia: A case report.
Hernandez L; Galeotti J; Gold S; Alexander TB
Pediatr Blood Cancer; 2024 May; ():e31098. PubMed ID: 38814256
[No Abstract] [Full Text] [Related]
29. Infrequent fractures and resilient bone mineral density: bone health in patients with Fanconi anemia.
Koo J; Howell JC; Hornung L; Sabulski A; Mehta PA; Davies SM; Myers KC
Haematologica; 2024 May; ():. PubMed ID: 38813733
[TBL] [Abstract][Full Text] [Related]
30. Modern management of Fanconi anemia.
Dufour C; Pierri F
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):649-657. PubMed ID: 36485157
[TBL] [Abstract][Full Text] [Related]
31. [Effects of titanium dioxide nanoparticles on circRNA expression profiles in human hepatocellular carcinoma cells HepG2].
Shi JQ; Ma Y; Zhang Y; Chen ZJ; Jia G
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):392-399. PubMed ID: 37291912
[TBL] [Abstract][Full Text] [Related]
32. Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer?
Martínez-Balsalobre E; Guervilly JH; van Asbeck-van der Wijst J; Pérez-Oliva AB; Lachaud C
Blood Rev; 2023 Jul; 60():101094. PubMed ID: 37142543
[TBL] [Abstract][Full Text] [Related]
33. Targeting RIPK1 kinase for modulating inflammation in human diseases.
Li W; Yuan J
Front Immunol; 2023; 14():1159743. PubMed ID: 36969188
[TBL] [Abstract][Full Text] [Related]
34. A novel RIPK1 inhibitor attenuates GVHD.
Hill GR; Koyama M
Blood; 2023 Mar; 141(9):969-970. PubMed ID: 36862437
[No Abstract] [Full Text] [Related]
35. A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis.
Yu X; Ma H; Li B; Ji Y; Du Y; Liu S; Li Z; Hao Y; Tian S; Zhao C; Du Q; Jin Z; Zhu X; Tian Y; Chen X; Sun X; Yang C; Zhu F; Ju J; Zheng Y; Zhang W; Wang J; Yang T; Wang X; Li J; Xu X; Du S; Lu H; Ma F; Zhang H; Zhang Y; Zhang X; Hu S; He S
Blood; 2023 Mar; 141(9):1070-1086. PubMed ID: 36356302
[TBL] [Abstract][Full Text] [Related]
36. Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.
Fiesco-Roa MÓ; García-de Teresa B; Leal-Anaya P; van 't Hek R; Wegman-Ostrosky T; Frías S; Rodríguez A
Front Oncol; 2022; 12():949435. PubMed ID: 36091172
[TBL] [Abstract][Full Text] [Related]
37. Multimolecular characteristics and role of BRCA1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis.
Wang R; Zhang J; Cui X; Wang S; Chen T; Niu Y; Du X; Kong J; Wang L; Jiang Y
World J Surg Oncol; 2023 Mar; 21(1):91. PubMed ID: 36907870
[TBL] [Abstract][Full Text] [Related]
38. Fanconi anemia-associated signature in cancer.
Danovi S
Nat Genet; 2023 Jan; 55(1):1. PubMed ID: 36639507
[No Abstract] [Full Text] [Related]
39. The DNA-damage kinase ATR activates the FANCD2-FANCI clamp by priming it for ubiquitination.
Sijacki T; Alcón P; Chen ZA; McLaughlin SH; Shakeel S; Rappsilber J; Passmore LA
Nat Struct Mol Biol; 2022 Sep; 29(9):881-890. PubMed ID: 36050501
[TBL] [Abstract][Full Text] [Related]
40. Replication stress as a driver of cellular senescence and aging.
Herr LM; Schaffer ED; Fuchs KF; Datta A; Brosh RM
Commun Biol; 2024 May; 7(1):616. PubMed ID: 38777831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
